Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran
Article in Journal of Medical Economics (January 2019)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (January 2019)
Article in International Journal of Molecular Sciences (January 2019)
Article in Multiple Sclerosis Journal (July 2017)